Adjunctive Cannabidiol for Recovery From Opioid Study

NCT06940674 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use Disorder (OUD)

Interventions

DRUG: Cannabidiol
DRUG: Placebo

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]
[object Object]
[object Object]